Today, 20,627 Shares of Morgan Stanley (MS) are sold by Trilogy Global Advisors LP

Today, 20,627 Shares of Morgan Stanley (MS) are sold by Trilogy Global Advisors LP

Trilogy Global Advisors LP decreased its position in shares of Morgan Stanley (NYSE:MS) by 2.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 745,510 shares of the financial services provider’s stock after selling 20,627 shares during the period. Trilogy Global Advisors LP’s holdings in Morgan Stanley were worth $23,900,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. FineMark National Bank & Trust raised its stake in Morgan Stanley by 2.0% in the second quarter. FineMark National Bank & Trust now owns 4,332 shares of the financial services provider’s stock valued at $113,000 after buying an additional 84 shares in the last quarter. First Manhattan Co. raised its stake in Morgan Stanley by 2.4% in the third quarter. First Manhattan Co. now owns 4,294 shares of the financial services provider’s stock valued at $137,000 after buying an additional 100 shares in the last quarter. Assetmark Inc. raised its stake in Morgan Stanley by 291.1% in the second quarter. Assetmark Inc. now owns 5,323 shares of the financial services provider’s stock valued at $138,000 after buying an additional 3,962 shares in the last quarter. Synovus Financial Corp raised its stake in Morgan Stanley by 11.3% in the second quarter. Synovus Financial Corp now owns 5,418 shares of the financial services provider’s stock valued at $141,000 after buying an additional 549 shares in the last quarter. Finally, Trust Co. of Vermont raised its stake in Morgan Stanley by 24.6% in the third quarter. Trust Co. of Vermont now owns 4,597 shares of the financial services provider’s stock valued at $147,000 after buying an additional 907 shares in the last quarter. Institutional investors and hedge funds own 85.32% of the company’s stock.

Morgan Stanley (NYSE:MS) opened at 40.91 on Friday. Morgan Stanley has a one year low of $21.16 and a one year high of $41.20. The firm has a market cap of $76.62 billion, a PE ratio of 16.44 and a beta of 1.87. The company’s 50-day moving average is $34.90 and its 200 day moving average is $30.18.

Morgan Stanley (NYSE:MS) last issued its quarterly earnings data on Wednesday, October 19th. The financial services provider reported $0.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.63 by $0.17. The business earned $8.91 billion during the quarter, compared to analyst estimates of $8.17 billion. Morgan Stanley had a net margin of 14.44% and a return on equity of 7.57%. The firm’s quarterly revenue was up 14.7% on a year-over-year basis. During the same quarter last year, the business earned $0.34 EPS. Equities analysts anticipate that Morgan Stanley will post $2.71 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, November 15th. Investors of record on Monday, October 31st were issued a $0.20 dividend. The ex-dividend date of this dividend was Thursday, October 27th. This represents a $0.80 dividend on an annualized basis and a yield of 1.95%. Morgan Stanley’s dividend payout ratio (DPR) is presently 32.00%.

Several analysts have recently weighed in on MS shares. Vetr lowered shares of Morgan Stanley from a “hold” rating to a “sell” rating and set a $32.18 target price on the stock. in a research report on Tuesday, November 8th. Barclays PLC lifted their target price on shares of Morgan Stanley from $32.00 to $35.00 and gave the company an “equal weight” rating in a research report on Thursday, October 20th. Guggenheim upgraded shares of Morgan Stanley from a “neutral” rating to a “buy” rating in a research report on Thursday, October 20th. Zacks Investment Research upgraded shares of Morgan Stanley from a “hold” rating to a “buy” rating and set a $37.00 target price on the stock in a research report on Friday, October 21st. Finally, Sandler O’Neill lowered shares of Morgan Stanley from a “buy” rating to a “hold” rating and set a $33.00 target price on the stock. in a research report on Thursday, October 6th. Three investment analysts have rated the stock with a sell rating, eleven have given a hold rating and fifteen have assigned a buy rating to the company. Morgan Stanley currently has a consensus rating of “Hold” and a consensus target price of $32.59.

In other Morgan Stanley news, CFO Paul C. Wirth sold 18,929 shares of the firm’s stock in a transaction that occurred on Tuesday, August 30th. The shares were sold at an average price of $31.70, for a total transaction of $600,049.30. Following the completion of the transaction, the chief financial officer now owns 195,748 shares in the company, valued at approximately $6,205,211.60. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, COO James A. Rosenthal sold 111,200 shares of the firm’s stock in a transaction that occurred on Friday, November 18th. The stock was sold at an average price of $40.34, for a total transaction of $4,485,808.00. Following the transaction, the chief operating officer now owns 294,261 shares of the company’s stock, valued at approximately $11,870,488.74. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by corporate insiders.

About Morgan Stanley

Morgan Stanley is a financial holding company. The Company is a global financial services firm that, through its subsidiaries and affiliates, advises, and originates, trades, manages and distributes capital for, governments, institutions and individuals. Its segments include Institutional Securities, Wealth Management and Investment Management.

Receive News & Ratings for Morgan Stanley Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Morgan Stanley and related companies with MarketBeat.com’s FREE daily email newsletter.

Related posts

Leave a Comment